No post-transplant pure red cell aplasia development in 106 major ABO incompatible cord blood transplantation
Bone Marrow Transplant
.
2019 May;54(5):765-768.
doi: 10.1038/s41409-018-0375-2.
Epub 2018 Nov 6.
Authors
Sachie Wada
1
,
Yuki Asano-Mori
2
,
Hisashi Yamamoto
1
,
Mitsuhiro Yuasa
1
,
Kosei Kageyama
1
,
Daisuke Kaji
1
,
Aya Nishida
1
,
Kazuya Ishiwata
1
,
Shinsuke Takagi
1
,
Go Yamamoto
1
,
Naoyuki Uchida
1
,
Akiko Yoneyama
3
,
Shigeyoshi Makino
4
,
Shuichi Taniguchi
1
Affiliations
1
Department of Hematology, Toranomon Hospital, Tokyo, Japan.
2
Department of Hematology, Toranomon Hospital, Tokyo, Japan. yukia-tky@umin.ac.jp.
3
Department of Clinical laboratory, Toranomon Hospital, Tokyo, Japan.
4
Department of Transfusion Medicine, Toranomon Hospital, Tokyo, Japan.
PMID:
30401968
DOI:
10.1038/s41409-018-0375-2
No abstract available
Publication types
Clinical Trial
Letter
MeSH terms
ABO Blood-Group System / blood*
Cord Blood Stem Cell Transplantation*
Female
Humans
Male
Middle Aged
Red-Cell Aplasia, Pure / blood*
Red-Cell Aplasia, Pure / epidemiology*
Substances
ABO Blood-Group System